Donazioni 15 September, 2024 – 1 Ottobre, 2024
Sulla raccolta fondi
ricerca dei libri
libri
Donazioni:
69.0% compiuto
Entrare
Entrare
gli utenti autorizzati hanno accesso a:
raccomandazioni personali
Telegram bot
cronologia dei download
inviare a email o Kindle
gestione delle raccolte
salvare nei preferiti
Personale
Richieste di libro
Studia
Z-Recommend
Elenco libri
Più popolari
Categorie
Partecipazione
Donare
Caricamenti
Litera Library
Dona i libri cartacei
Aggiungi i libri cartacei
Search paper books
Mio LITERA Point
Ricerca termini
Main
Ricerca termini
search
1
Advocate Study Pocket Protocol (CL010_168)
MedPace
ChemoCentryx
ccx
thc
dose
ancl
placebo
cyc
ents
bvas
protocol
oral
protoco
stucly
patients
patient
avacopan
weck
weeks
prior
azathi
events
adverse
anti
predni
rate
laboratory
acco
reco
november
ritu
remi
renal
chemocentryx
ial
sone
cati
dosc
lnc
clini
cl0
cnt
gator
glucoco
event
items
medi
stud
urin
ient
unt
wbc
Anno:
2016
Lingua:
english
File:
PDF, 4.71 MB
I tuoi tag:
0
/
0
english, 2016
2
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Kidney Disease: Improving Global Outcomes (KDIGO)
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group & Jürgen Floege & David R.W. Jayne & Jan-Stephan F. Sanders & Vladimír Tesar & Brad H. Rovin
anca
vasculitis
kidney
patients
rituximab
cyclophosphamide
evidence
therapy
maintenance
remission
guideline
clinical
azathioprine
induction
relapse
antibody
cytoplasmic
versus
antineutrophil
certainty
figure
outcomes
glucocorticoids
kdigo
risk
s116
s71
suppl
studies
international.org
www.kidney
plasma
recommendation
pr3
rate
recommendations
dose
glucocorticoid
nephrology
supplementary
effect
rcts
immunosuppressive
oral
compared
glomerular
gfr
systematic
avacopan
mpo
Anno:
2024
Lingua:
english
File:
PDF, 1.87 MB
I tuoi tag:
0
/
0
english, 2024
3
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Kidney Disease: Improving Global Outcomes (KDIGO)
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group & Jürgen Floege & David R.W. Jayne & Jan-Stephan F. Sanders & Vladimír Tesar & Brad H. Rovin
anca
vasculitis
kidney
patients
rituximab
cyclophosphamide
evidence
therapy
maintenance
remission
guideline
clinical
azathioprine
induction
relapse
antibody
cytoplasmic
versus
antineutrophil
certainty
figure
outcomes
glucocorticoids
kdigo
risk
s116
s71
suppl
studies
international.org
www.kidney
plasma
recommendation
pr3
rate
recommendations
dose
glucocorticoid
nephrology
supplementary
effect
rcts
immunosuppressive
oral
compared
glomerular
gfr
systematic
avacopan
mpo
Anno:
2024
Lingua:
english
File:
PDF, 1.56 MB
I tuoi tag:
0
/
0
english, 2024
1
Segui
questo link
o cerca il bot "@BotFather" in Telegram
2
Invia il comando /newbot
3
Inserisci un nome del tuo bot
4
Inserisci un nome utente del bot
5
Copia l'ultimo messaggio da BotFather e incollalo qui
×
×